PC materials are clinically proven and add value to our customers' products. We work together in the way that suits our partners and are very flexible when agreeing commercial arrangements.
The clinical benefits of medical devices incorporating PC are well-established and these products enjoy a number of FDA allowed label claims. The value added by our technology is endorsed through use by major medical device companies around the world. This, coupled with the intuitive technology story, provides licensees with a convincing marketing rationale.
Products incorporating PC are now sold across the world in a variety of clinical areas including:
- Interventional cardiology
- Cardiac surgery
PC materials are used to provide clinical benefits that can give medical device companies a highly differentiated product. Potential benefits include:
- Enhanced product and brand performance
- Premium pricing or value-added positioning
- Opportunity to gain market share
- Reduced market share erosion
With in-house expertise in materials development, process validation, product approval and commercialisation, Vertellus Biomaterials is in an ideal position to assist healthcare companies in putting the benefits of our materials to work in their applications.